Campari Group (MIL: CPR): FY2026 annual results (publication approx. March 2027) show organic net revenue growth of at least 2.5% year-on-year
Campari Group reported H1 2026 organic revenue growth of +2.7% (net sales €1.51bn) and Q2 2026 +2.5% (The Spirits Business, 31 July 2026). Management raised FY2026 guidance to at least +3% organic growth. Five consecutive quarters of positive organic growth underpin consistency. Aperol (+3.3%), Campari (+2.3%) and Espolòn (US) drive growth. The $7M US tariff impact was already absorbed in H1. The 2.5% threshold is well below guidance (+3%) and H1 performance. Risks: US demand weakness from recession fears, adverse FX (EUR/USD), unexpected brand sales softness.
82%